Roche Diabetes Care, Inc. Sustainability Profile
Roche Diabetes Care, Inc., a prominent player in the diabetes management industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1896, Roche has established itself as a leader in innovative healthcare solutions, particularly in diabetes care. The company is renowned for its cutting-edge blood glucose monitoring systems, insulin delivery devices, and digital health solutions, which empower patients to manage their diabetes effectively. Roche Diabetes Care's unique approach combines advanced technology with user-friendly design, ensuring that individuals with diabetes can easily monitor their health. With a strong market position, the company has achieved notable milestones, including the development of the Accu-Chek product line, which is widely recognised for its reliability and accuracy. Through continuous innovation and a commitment to improving patient outcomes, Roche Diabetes Care remains at the forefront of diabetes management solutions.
DitchCarbon Score
How does Roche Diabetes Care, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Diabetes Care, Inc.'s score of 83 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Diabetes Care, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Roche Holding AG, which influences its climate commitments and emissions reporting. As part of its corporate family, Roche Diabetes Care inherits emissions data and climate initiatives from Roche Holding AG. However, there are no documented reduction targets or specific climate pledges available for Roche Diabetes Care at this time. The absence of detailed emissions data and reduction initiatives suggests that the company may still be in the process of establishing its own specific climate strategies, despite being part of a larger organisation with established commitments. Roche Holding AG, the parent company, may have its own emissions data and climate targets, which could indirectly impact Roche Diabetes Care's future commitments. As the company continues to align with its parent organisation's sustainability goals, it is expected to develop its own strategies to address carbon emissions and contribute to broader climate action efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Roche Diabetes Care, Inc.'s Industry?
How Carbon Intensive is Roche Diabetes Care, Inc.'s Location?
Roche Diabetes Care, Inc.'s Scope 3 Categories Breakdown
Roche Diabetes Care, Inc.'s Scope 3 emissions, which decreased by 8% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Roche Diabetes Care, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Roche Diabetes Care, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
